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Protocol
AbstrACt
Introduction Sedentary behaviour is a distinct risk factor 
for cardiovascular disease (CVD) and could partly explain 
the increased prevalence of CVD in people with spinal 
cord injury (SCI). Interrupting prolonged sitting periods 
with regular short bouts of walking acutely suppresses 
postprandial glucose and lipids in able-bodied individuals. 
However, the acute CVD risk marker response to breaking 
up prolonged sedentary time in people with SCI has not 
been investigated.
Methods and analysis A randomised two-condition 
laboratory crossover trial will compare: (1) breaking up 
prolonged sedentary time with 2 min moderate-intensity 
arm-crank activity every 20 min, with (2) uninterrupted 
prolonged sedentary time (control) in people with SCI. 
Outcomes will include acute effects on postprandial 
glucose, insulin, lipids and blood pressure. Blood samples 
will be collected and blood pressure measured at regular 
intervals during each 5½-hour condition.
Ethics and dissemination This study was approved by 
the Cambridge South National Health Service Research 
Ethics Committee. This research will help determine if 
breaking up prolonged sedentary time could be effective 
in lowering CVD risk in people with SCI. The findings of the 
research will be published in a peer-reviewed journal and 
disseminated to relevant user groups.
trial registration number ISRCTN51868437; Pre-results.
IntroduCtIon 
There is a global incident rate of 180 000 
traumatic spinal cord injury (SCI) cases 
each year with a prevalence of over 40 000 
in the UK.1 2 Cardiovascular disease (CVD) 
is a leading cause of death in individuals 
with SCI,3 and this population has a signifi-
cantly increased risk of heart disease and 
stroke compared with able-bodied individ-
uals.4 Traditional risk factors for CVD include 
impaired glucose tolerance, central obesity, 
high triglycerides, low high-density lipo-
protein cholesterol (HDL) and high blood 
pressure. These risk factors often exacer-
bate significantly as a consequence of SCI,5 
and a plethora of research has documented 
impaired glucose tolerance and adverse lipid 
profiles in individuals with SCI.5 6 The clus-
tering of ≥2 and ≥3 risk factors is prevalent 
in 87% and 72% of SCI individuals, respec-
tively,7 which is markedly higher compared 
with the able-bodied population.8 This milieu 
of metabolic disturbances after SCI may be 
due to increases in body fat resulting from 
an imbalance in energy intake and expendi-
ture.5 Excess fat accumulation, particularly in 
the visceral region, is associated with inflam-
mation that is causal in glucose intolerance 
and dyslipidaemia,5 9 thus promoting athero-
genesis that would increase the risk of CVD in 
this population.10 
strengths and limitations of this study
 ► This study uses a randomised crossover design to 
investigate, for the first time, cardiovascular disease 
risk marker responses to breaking up prolonged 
sedentary time in individuals with paraplegia.
 ► Regular collection of blood samples will permit 
robust time course and incremental area under 
the curve calculations for primary and secondary 
outcomes.
 ► Due to the acute nature of the study, the long-term 
cardiovascular disease risk marker responses to a 
chronic intervention will remain unknown.
 ► The cardiovascular disease risk marker responses 
to breaking up prolonged sedentary time in people 
with tetraplegia still requires investigation.
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Postprandial glucose and lipid concentrations are 
strong independent predictors of future CVD inci-
dence, even in those without diabetes.11 There is a dose–
response relationship between postprandial glucose area 
under the curve (AUC) and CVD risk, while progression 
of carotid atherosclerosis can be prevented by attenua-
tion of postprandial glucose concentrations.12 13 Impaired 
postprandial glucose metabolism was observed in 50% 
and 62% of individuals with paraplegia and tetraplegia, 
respectively, compared with 18% in able-bodied individ-
uals.6 This impaired glucose tolerance in SCI is charac-
terised by hyperinsulinaemia, which suggests that there 
is tissue-level resistance to insulin.14 In individuals with 
paraplegia, there appears to be no difference in post-
prandial glucose responses between those with complete 
versus incomplete lesions.15 16 Although postprandial 
lipaemic responses have not been compared between 
individuals with complete and incomplete lesions, fasting 
lipid levels do not differ between these groups.17 There 
does, however, appear to be an exaggerated postpran-
dial lipaemic response in individuals with paraplegia 
compared with able-bodied individuals.18 These observa-
tions are of potential concern as the high dietary intake 
of carbohydrate and fat in individuals with SCI19 may 
lead to repeated exaggerated elevations in glucose and 
lipids following food intake. It is thus pertinent to identify 
interventions to reduce postprandial glucose and lipid 
responses in individuals with SCI to reduce their CVD 
risk.
Physical activity guidelines have been developed specif-
ically for the SCI population that recommend engaging 
in at least 30 min of moderate-to-vigorous physical activity 
(MVPA) three times per week for CVD health benefits.20 
However, it is estimated that 37%–50% of this population 
engage in no leisure-time physical activity whatsoever.21 22 
Reduced levels of physical activity are proposed to largely 
account for the increased CVD risk in SCI with reduced 
levels of leisure-time physical activity associated with 
increased body fat, insulin resistance and systolic blood 
pressure.22 23 However, sedentary behaviour (ie, any waking 
behaviour in a sitting, reclining or lying posture with low 
energy expenditure)24 is now recognised as being a signif-
icant CVD risk factor in the able-bodied population, inde-
pendent of MVPA.25 Experimental studies in able-bodied 
individuals have reported an acute reduction in postpran-
dial glucose, insulin, triglycerides and blood pressure in 
response to breaking up prolonged sedentary time with 
2 min bouts of light or moderate-intensity walking every 
20 min.26–29 However, no research has examined whether 
postprandial CVD risk marker responses are attenuated 
in response to breaking up prolonged sedentary time in 
individuals with SCI.
The primary aim of this study is therefore to compare 
the acute CVD risk marker responses in individuals with 
SCI to (1) breaking up prolonged sedentary time, with 
(2) uninterrupted sedentary time. The CVD risk markers 
that will be studied include postprandial glucose (primary 
outcome), insulin and lipids, and systolic and diastolic 
blood pressures (secondary outcomes) based on evidence 
that these markers predict CVD outcomes and are 
adversely affected by SCI. It is hypothesised that breaking 
up prolonged sedentary time will result in favourable 
CVD risk marker responses compared with uninterrupted 
sedentary time in individuals with paraplegia. This could 
identify a novel strategy for the prevention of CVD in SCI 
that would warrant further evaluation.
MEthods And AnAlysIs
study design
A randomised two-condition crossover design will be used 
in accordance with the Standard Protocol Items: Recom-
mendations for Interventional Trials (SPIRIT) state-
ment.30 The study schedule can be seen in figure 1. All 
research will take place at the University of Bedfordshire 
Sport and Exercise Science Laboratories. After prelimi-
nary measures, participants will complete two experi-
mental conditions in a randomised order. The conditions 
will be separated by ≥6 days to eliminate any potential 
carry-over effects. Condition order will be randomised by 
a researcher independent from the study using comput-
er-generated random numbers (block randomisation 
with balanced block sizes).
Participants
Inclusion criteria
Males and females aged 18–60 years; chronic SCI (≥1 year 
since injury), individuals with a traumatic SCI below T5 
Figure 1 Study schedule.
 o
n
 31 July 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-021936 on 22 June 2018. Downloaded from 
3Withers TM, et al. BMJ Open 2018;8:e021936. doi:10.1136/bmjopen-2018-021936
Open access
(mid to low level paraplegia), individuals with a non-trau-
matic SCI (as defined by the International Spinal Cord 
Injury Data Sets for non-traumatic SCI31) that present 
with mid to low level paraplegia. Including only indi-
viduals with injuries below T5 will ensure sympathetic 
innervation to the major organs at the T5 level so that 
heart rate and catecholamine responses would be unaf-
fected by injury32 and thus minimise the potential that 
innervation variations could have on the study outcomes. 
Individuals with paraplegia who have complete or incom-
plete lesions will be included based on evidence that 
these groups do not differ with respect to postprandial 
glucose metabolism (primary outcome).15 16 Individuals 
who express an interest in taking part in the study will 
be required to indicate their spinal cord lesion level and 
completeness of injury via a questionnaire and asked to 
provide the research team with a copy of medical records 
to confirm injury level and American Spinal Injury Asso-
ciation (ASIA) impairment scale classification prior to 
preliminary measures.
Exclusion criteria
Individuals who regularly engage in >300 min/week of 
MVPA as such high levels of physical activity may offset 
the detrimental association of sedentary time with health 
outcomes33; history of severe cardiovascular complica-
tions; hypotension (resting blood pressure <90/60 mm 
Hg); body mass index >45 kg/m2; a history of autonomic 
dysreflexia; pregnancy; taking glucose-lowering medi-
cation; smokers; diagnosed diabetes, renal failure, liver 
disease, major illness or other health issues that may limit 
the ability to perform the physical activity protocols.
recruitment
Participants will be recruited through organisations 
and charities relevant to individuals with SCI, including 
the National Spinal Injuries Centre, Stoke Mandeville 
Hospital, Buckinghamshire NHS Healthcare Trust; local 
sport and activity clubs; and local community groups. Mail 
outs, social media, information on websites, posters, flyers 
and visits from the research team will be used to provide 
information on the study to potentially eligible individuals 
who can then express their interest to the research team 
in taking part in the study. Written informed consent will 
be obtained by a member of the research team prior to 
participation in any testing protocols (see online supple-
mentary file). As an incentive, participants will receive a 
£25 shopping gift voucher for each main condition they 
complete and will have all travel expenses paid.
Preliminary measures
Participants will attend a preliminary testing session 
where they will have body mass measured using wheel-
chair double beam scales (300 series; Marsden, London, 
UK). They will also have body fat and lean tissue mass 
(and per cent) determined for the whole body and 
regionally via whole-body scans using dual-energy X-ray 
absorptiometry (DXA; GE Medical Systems; Chalfont 
St Giles, UK) in line with previous research.34–36 During 
DXA measures, participants will be positioned as closely 
as possible to standard protocols, and Velcro restraints 
will be fastened around the participants’ knees and ankles 
to maintain correct position of the legs during scanning. 
Participants will be offered a wedge to be used as a pillow 
for comfort. Waist circumference will be measured using 
the International Society for the Advancement of Kinan-
thropometry (ISAK) International Standards for Anthro-
pometric Assessment guidelines.37 38 These measures will 
be taken in the standing position for participants who 
are able to maintain this posture and in a supine posi-
tion for participants who are not able to stand.38 Resting 
blood pressure will be measured on the left arm, while 
seated, three times after the participant has rested for 
5 min with the lowest readings being recorded. Following 
this, participants will be familiarised with use of the Borg 
6–20 Rating of Perceived Exertion (RPE) scale.39 They 
will then cycle using an arm ergometer (Lode Angio; 
Lode, Netherlands) to determine the intensity (power 
output) that yields an RPE of 13 (somewhat hard) in line 
with previous sedentary behaviour research.26 40 Partici-
pants will be asked to cycle at ~70 rpm during the test. 
The test will start at a low intensity (~20 Watts) and the 
participants will then indicate their RPE at 1 min inter-
vals. The resistance will then be increased by 5–20 Watts 
based on the participants’ RPE until an RPE of 13 has 
been achieved, at which point the test will be terminated. 
The test is expected to take no longer than 15 min. The 
intensity that corresponds to an RPE of 13 during the test 
will be recorded for each participant and used for the 
physical activity breaks described in the respective main 
condition below. The use of the Borg 6–20 RPE scale has 
acceptable validity in individuals with SCI to determine 
physical activity intensity.41 This method is also suggested 
as a practical approach for healthcare professionals and 
scientists as oxygen consumption testing equipment is 
costly and not available in many rehabilitation centres 
and community settings.41
Experimental protocol
Figure 2 shows the experimental protocol. Participants will 
be instructed to refrain from caffeine, alcohol and exer-
cise for 48 hours prior to each experimental condition. 
They will also be provided with a food diary and digital 
weighing scales to record volume and timings of all food 
and liquids consumed in the 24-hour period prior to the 
first experimental condition. Participants will be asked to 
replicate their diet the day prior to the subsequent exper-
imental condition.42 On condition days, participants will 
attend in the morning following an overnight fast and 
avoid active travel to the laboratory. On arrival, resting 
blood pressure will be measured after 5 min rest; two 
measures will be taken and the lowest of these recorded. 
A fasting capillary blood sample will then be collected. 
Participants will commence the 5½-hour condition period 
following consumption of a standardised breakfast. The 
two experimental conditions are as follows:
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1. Uninterrupted sedentary time (SED): participants will re-
main seated and inactive in their wheelchair or a stan-
dard chair at a desk during this condition.
2. Sedentary time interrupted with physical activity breaks (SED-
ACT): participants will complete 2 min of moderate-in-
tensity arm-crank activity every 20 min at ~70 rpm using 
the Lode Angio arm ergometer. These 15 breaks will 
equate to a total of 30 min physical activity.
The SED-ACT protocol was selected based on previous 
research that reported a significant reduction in 5-hour 
postprandial glucose in response to breaking up 
prolonged sitting time with 2 min light-intensity walking 
every 20 min versus uninterrupted sitting in able-bodied 
participants.28 An RPE of 13 for the physical activity inten-
sity was selected in line with previous research,26 42 and 
the Borg 6–20 RPE scale may be used to assess and regu-
late upper-body physical activity at moderate-to-vigorous 
intensity in adults with chronic SCI.41 Moderate-intensity 
physical activity was selected as it is well tolerated, can be 
performed safely and is recommended for health risk 
reduction in individuals with SCI.20 43
Participants will be permitted to work on a laptop 
computer, read, talk or watch DVDs during each condi-
tion. This will be standardised by asking participants 
to engage in the same activities during each of the two 
experimental conditions. Except during the activity 
bouts, participants will remain inactive and only leave 
their desk to void and consume standardised meals in a 
kitchen adjacent to the test laboratory; participants will be 
aided by a member of the research team when moving to 
these locations so that they remain inactive. A researcher 
will be present to ensure compliance with the protocols 
throughout all conditions.
Meal and water consumption
Standardised meals will be consumed immediately prior 
to the start of each experimental condition and at 3 hours, 
each providing 30% of estimated daily energy require-
ments for each participant.44 Participants will be asked to 
consume each meal within a 15 min time period. The time 
taken to consume the meals will be recorded for the first 
condition, and participants will be asked to replicate this 
time as closely as possible in the subsequent condition. 
Breakfast will consist of bran flakes, whole milk, croissant, 
butter and orange juice (54% carbohydrate, 34% fat, 12% 
protein) and lunch will be a chicken sandwich, salted crisps 
and apple (54% carbohydrate, 34% fat, 12% protein). The 
macronutrient composition of meals in the current study 
has been selected as it is generally representative of UK 
guidelines for a balanced diet.45 The glycaemic index for 
these breakfast and lunch meals is 43 and 72, respectively. 
Glycaemic index values for each food item were obtained 
from the International Tables of Glycaemic Index and 
Glycaemic Load Values 2008,46 and meal glycaemic index 
was calculated using weighted means of the glycaemic 
index values for the component foods.47 Water will be avail-
able ad libitum during the first condition, and this volume 
of intake will be provided at standardised regular intervals 
in the subsequent condition.
blood collection and biochemistry
Finger prick blood samples will be collected into two 
EDTA-containing microvettes (Microvette CB300 EDTA, 
Sarstedt, Leicester, UK) at baseline and at 30, 60, 90, 120, 
180, 210, 240, 300 and 330 min. Blood samples will be 
collected before the hourly activity bouts in SED-ACT. At 
each time point, approximately 600 µL of whole blood will 
be collected. Blood glucose concentrations will be anal-
ysed immediately using the YSI 2300 STAT plus glucose 
and lactate analyzer (YSI, Yellow Springs, Ohio, USA) 
from 30 µL of blood from one microvette. Additional 
30 µL volumes of whole blood will be aliquoted onto two 
separate Reflotron test strips (Roche Diagnostics, Burgess 
Hill, UK) for the measurement of triglyceride and HDL 
concentrations using the Reflotron Plus system (Roche 
Diagnostics, Burgess Hill, UK). The remaining whole 
blood (~490 µL) will be centrifuged at 2500 x g for 5 min 
(Heraeus Pico 17, Thermo Scientific, Loughborough, 
UK) and the plasma then stored at −80°C. An ELISA 
kit will be used to determine plasma concentrations of 
insulin (Mercodia, Uppsala, Sweden).
blood pressure
Blood pressure will be measured at baseline as described 
above followed by single readings taken at 60, 120, 180, 
240, 300 and 330 min. Readings will be taken 5 min before 
the hourly activity bouts in SED-ACT. Blood pressure 
will be measured using an automated oscillatory blood 
Figure 2 Schematic of experimental protocol.
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pressure monitor (Omron M5-I; Omron Matsusaka, 
Matsusaka, Japan).
study outcomes
Primary outcome
The primary outcome for the study is within-participant, 
between condition postprandial glucose net incremental 
AUC (iAUC).11
Secondary outcomes
These include within-participant, between condition 
mean systolic and diastolic blood pressures, and net iAUC 
for postprandial triglycerides, HDL and insulin. Positive 
iAUC and total AUC will also be calculated for postpran-
dial glucose, insulin, triglycerides and HDL to permit 
comparisons with previous studies.
Feasibility measures
To assess feasibility of the trial, participant dropout, 
number of experimental sessions completed, fatigue at 
the beginning and end of each day rated on an 11-point 
(0 ‘not fatigued at all’ to 10 ‘extremely fatigued’) Visual 
Analogue Scale (VAS) and the degree of difficulty in 
completing each experimental condition rated on an 
11-point VAS (0 ‘not difficult at all’ to 10 ‘extremely diffi-
cult’) will be recorded. Participants will also complete 
the Physical Activity Enjoyment Scale48 at the end of the 
SED-ACT condition and report their enjoyment on a 
200 mm VAS49 (‘Enjoyment’) 20 min after the last activity 
bout in the SED-ACT condition. Participants will also 
report on the same scale how enjoyable they would find 
it to engage in this form of physical activity most days of 
the week in the coming month (‘Expected enjoyment’).
Psychological outcomes
Correlates of sedentary behaviour will be measured 
immediately before and after each experimental condi-
tion to explore whether participants’ mood, affect, well-
being and social cognitions regarding their ability to 
overcome being sedentary may differ in response to the 
SED-ACT condition compared with the SED condition. 
These measures will be based on the Theory of Planned 
Behaviour50 using standardised wording formats51 that 
will include overcoming barriers (self-efficacy/perceived 
behavioural control), attitudes, intentions and action 
planning. The following questionnaires will be completed 
in this order: psychological well-being using the National 
Well-being Measurement52; the Warwick Edinburgh 
Mental Well-Being Scale53; current mood using the short 
Positive and Negative Affect Scale54; and an adapted 
version of the Schwarzer and Renner55 Physical Exercise 
Self-Efficacy Scale to measure self-efficacy to avoid long 
periods of sedentary time. These measures will be taken 
at the end of each experimental condition (330 min) 
meaning that each questionnaire will be completed 
within 45 min following the last bout of activity in the 
SED-ACT condition. This is an appropriate time frame 
based on evidence that mood and affect are enhanced 
for 3–4 hours following a single session of exercise.56 
Although between-participant variation in the time taken 
to complete each questionnaire is anticipated, within-par-
ticipant variation is expected to be limited, therefore 
permitting valid between-condition comparisons.
sample size calculations
Sample size calculations were performed using GPower.57 
Previous research reported a 16% reduction (effect size, 
F=0.61) in 5-hour postprandial glucose total AUC when 
breaking up prolonged sedentary time with 2 min light-in-
tensity walking every 20 min versus uninterrupted sitting 
in able-bodied participants.28 As this study will use arm 
cranking (localised muscular contractions) as opposed to 
walking where a larger muscle mass is required, a smaller 
effect may be observed. Based on this, it was estimated 
that 12 participants would be required for this complete 
two-treatment crossover design to detect a medium effect 
size (F=0.4) with a within-person correlation of 0.6, 80% 
power, and an α of 0.05. To allow for potential with-
drawals, a total of 18participants will be recruited.
statistical analysis
Linear mixed models will be used to determine differences 
in the primary and secondary outcome variables between 
the conditions. All models will adjust for potential covari-
ates explaining residual outcome variances (age, body 
fat%, gender, lesion level, completeness of lesion and 
preprandial outcome values). Statistical significance will 
be accepted as p≤0.05. Cohen’s d effect sizes will be calcu-
lated to describe the magnitude of differences between 
conditions.58 Individuals’ responses for CVD risk marker 
outcomes will also be compared between the conditions 
to determine the number of participants who respond to 
the experimental protocols.
Patient and public involvement
Patients and public were not involved with the development 
of the research question, outcome measures or study design, 
nor will they be involved with the conduct of the study. The 
recruitment plan was informed based on feedback from 
patients and public. A summary of the study results will be 
provided to each of the study participants.
Ethics and dissemination
Personal information about potential and enrolled partic-
ipants will be stored in electronic format on password-pro-
tected computers or in hard copy format in locked filing 
cabinets at the University of Bedfordshire. Only members 
of the research team will have access to this information. 
All personal information will be destroyed after a period 
of 5 years. Individuals will be referred to in anonymised 
fashion in any published data.
The findings of this research will be disseminated to 
lay, academic, practice and policy-based audience via 
presentation at conference proceedings; publication in 
a peer-reviewed journal; websites, newsletters and social 
media; and summary reports to policy-makers and clin-
ical care partners. The final trial dataset will be made 
available as supplementary material when the findings 
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of the study are published in a peer-reviewed journal. 
Any protocol modifications will be communicated to 
the Cambridge South National Health Services Research 
Ethics Committee, recorded in the study’s ISRCTN clin-
ical trials registry and detailed in a journal publication of 
the study findings.
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